Product Information

CLARITHROMYCIN ER 500 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $1.8943 per EA under NDC 00591280560. Its NADAC has been published 645 times since Apr 9, 2014.

FDA first approved this application on Jun 24, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the clarithromycin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CLARITHROMYCIN ER 500 MG TAB

clarithromycin
$1.8943per EA
High Outlier

Strength

500 mg/1

NDC

00591280560

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CLARITHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065145

FDA Approved

6/24/2004

TE Code

AB

On Market Since

2/27/2014

Pharmacological Classes

Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
Macrolide Antimicrobial
Macrolides
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CLARITHROMYCIN ER 500 MG TAB has been published 645 times since Apr 9, 2014, and over the history we have for it it has declined 22.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8943 per EA
All-time high$6.1881 (Oct 13, 2021)
All-time low$1.8943 (Oct 21, 2026)
52-week high$3.1395
52-week low$1.8943
Median price$3.3390
Average price$3.5600
Largest weekly change+41.5% (Dec 19, 2018)
Weeks tracked645
Tracking sinceApr 9, 2014

Price History

1W

0.0%

1M

-1.2%

3M

-15.3%

6M

-37.4%

1Y

-43.2%

3Y

-56.1%

5Y

-49.1%

All

-22.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clarithromycin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLARITHROMYCIN ER 500 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN ER 500 MG TAB, manufactured by Actavis Pharma, Inc., is $1.8943 per EA (NDC 00591280560), effective Nov 11, 2026.

How has the price of CLARITHROMYCIN ER 500 MG TAB changed over time?

Over the history we have for it, the NADAC for CLARITHROMYCIN ER 500 MG TAB has declined 22.3%. It has been tracked across 645 weekly CMS publications since Apr 9, 2014.

What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN ER 500 MG TAB?

Since Apr 9, 2014, the NADAC for CLARITHROMYCIN ER 500 MG TAB has ranged from a low of $1.8943 (Oct 21, 2026) to a high of $6.1881 (Oct 13, 2021), with a median of $3.3390 per EA.

Are there cheaper alternatives to CLARITHROMYCIN ER 500 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of CLARITHROMYCIN ER 500 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLARITHROMYCIN ER 500 MG TAB?

CLARITHROMYCIN ER 500 MG TAB (NDC 00591280560) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.